Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives
In recent years, biotech, pharmaceutical and healthcare executives have been dealing with a global crisis created by the prevalence of multi-drug resistant organisms (MDROs), or as they have come to be referred to more commonly, superbugs. The Centers for Disease Control and Prevention (CDC)
